|
Originally published In Press as doi:10.1074/jbc.M106337200 on August 30, 2001
J. Biol. Chem., Vol. 276, Issue 44, 40949-40954, November 2, 2001
Lipid Binding-induced Conformational Change in Human
Apolipoprotein E
EVIDENCE FOR TWO LIPID-BOUND STATES ON SPHERICAL PARTICLES*
Hiroyuki
Saito §,
Padmaja
Dhanasekaran ,
Faye
Baldwin ,
Karl
H.
Weisgraber¶,
Sissel
Lund-Katz , and
Michael C.
Phillips
From the Joseph Stokes, Jr., Research Institute, the
Children's Hospital of Philadelphia, University of Pennsylvania School
of Medicine, Philadelphia, Pennsylvania 19104-4318 and the
¶ Gladstone Institute of Cardiovascular Diseases, Cardiovascular
Research Institute, and Department of Pathology, University of
California, San Francisco, California 94141
Received for publication, July 6, 2001, and in revised form, August 29, 2001
 |
ABSTRACT |
Apolipoprotein (apo) E contains two
structural domains, a 22-kDa (amino acids 1-191) N-terminal domain and
a 10-kDa (amino acids 223-299) C-terminal domain. To better understand
apoE-lipid interactions on lipoprotein surfaces, we determined the
thermodynamic parameters for binding of apoE4 and its 22- and 10-kDa
fragments to triolein-egg phosphatidylcholine emulsions using a
centrifugation assay and titration calorimetry. In both large (120 nm)
and small (35 nm) emulsion particles, the binding affinities decreased
in the order 10-kDa fragment 34-kDa intact apoE4 > 22-kDa fragment, whereas the maximal binding capacity of intact apoE4
was much larger than those of the 22- and 10-kDa fragments. These
results suggest that at maximal binding, the binding behavior of intact apoE4 is different from that of each fragment and that the N-terminal domain of intact apoE4 does not contact lipid. Isothermal titration calorimetry measurements showed that apoE binding to emulsions was an
exothermic process. Binding to large particles is enthalpically driven,
and binding to small particles is entropically driven. At a low surface
concentration of protein, the binding enthalpy of intact apoE4 ( 69
kcal/mol) was approximately equal to the sum of the enthalpies for the
22- and 10-kDa fragments, indicating that both the 22- and 10-kDa
fragments interact with lipids. In a saturated condition, however, the
binding enthalpy of intact apoE4 ( 39 kcal/mol) was less exothermic
and rather similar to that of each fragment, supporting the hypothesis
that only the C-terminal domain of intact apoE4 binds to lipid. We
conclude that the N-terminal four-helix bundle can adopt either open or closed conformations, depending upon the surface concentration of
emulsion-bound apoE.
 |
INTRODUCTION |
Apolipoprotein E
(apoE),1 a 299-residue plasma
apolipoprotein, plays a key role in lipoprotein metabolism, serving as
a high affinity ligand for the low density lipoprotein (LDL) receptor family and cell surface heparan sulfate proteoglycans (1, 2). Defective
binding of apoE to receptors causes cholesterol-rich lipoprotein
particles to accumulate in the plasma and is the mechanism of type III
hyperlipoproteinemia, a genetic disorder characterized by elevated
plasma cholesterol and triglyceride levels and accelerated coronary
artery disease (3). Association of apoE with lipid is required for its
high affinity binding to the LDL receptor (4). However, the molecular
details of the apoE-lipid interaction remain unclear.
ApoE is composed of two major structural and functional domains. The
22-kDa N-terminal domain contains the receptor-binding region, whereas
the 10-kDa C-terminal domain has a high affinity for lipid and is
responsible for lipoprotein binding (5, 6). The three-dimensional
structure of the N-terminal domain has been shown by x-ray
crystallographic studies to be an elongated globular four-helix bundle
(7, 8). Molecular area measurements at an air-water interface suggest
that the four-helix bundle can undergo a conformational change exposing
the hydrophobic faces to interact with lipid (9). Indeed, recent
studies with infrared spectroscopy (10), fluorescence resonance energy
transfer (11), and interhelical disulfide mutants of apoE N-terminal
domain (12) indicate that the four-helix bundle undergoes
conformational opening on phospholipid discs. Although these studies
show -helical reorganization upon lipid binding, the final
organization of the helices with respect to one another is unknown (12,
13).
The conformational reorganization of the N-terminal domain upon
interaction with lipid is associated with enhanced receptor binding
activity. NMR measurements showed that, when apoE was complexed
with dimyristoyl phosphatidylcholine (DMPC), lysines 143 and 146 in the
N-terminal domain (both in the LDL receptor-binding region) have
unusually low pKa values, reflecting local increases
in positive electrostatic potential caused by reorganization of the
-helices (14). The increased electrostatic potential, coupled with
enhanced exposure to the aqueous phase of the polar face of the
amphipathic-helix containing residues 136-150, seems to explain why
lipid association is required for the high affinity binding of apoE for
the LDL receptor (14, 15). However, certain apoE-containing lipoprotein
particles, such as intact chylomicrons, seem to be receptor-inactive
(16). In studies with perfused rat liver (17, 18) or phospholipase
A2-treated chylomicrons (19), it has been proposed that the
conformation of lipoprotein-bound apoE can be modulated by lipoprotein
lipid composition (20, 21) or other apolipoproteins (e.g. C
apolipoproteins) (22, 23). Based on the observation that
lipoprotein-associated apoE displays variable receptor binding ability,
Narayanaswami and Ryan (24) have proposed two lipid-bound states model
of apoE. The C-terminal domain anchors apoE to the lipoprotein
surfaces, whereas the N-terminal domain undergoes reversible
conformational changes that modulate receptor binding activity.
In the present study, we determined the quantitative contributions of
the N-terminal and the C-terminal domains of apoE to lipid binding on
lipoprotein-like emulsion particles with engineered apoE4 and its
22-kDa (residues 1-191) and 10-kDa (residues 223-299) fragments.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Egg yolk phosphatidylcholine (PC) and triolein
were purchased from Sigma, and stock solutions were stored in
chloroform/methanol (2:1) under nitrogen at 20 °C.
[14C]Formaldehyde (40-60 Ci/mol) in distilled water was
purchased from PerkinElmer Life Sciences. NaCNBH3 (Aldrich)
was recrystallized from methylene chloride before use (25). All other
salts and reagents were analytical grade.
Bacteriological media were obtained from Fisher. The prokaryotic
expression vector pET32a was from Novagen (Madison, WI), and the
competent Escherichia coli strain BL21 star (DE3) was from
Invitrogen (Carlsbad, CA). The competent E. coli strain
DH5 was from Life Technologies, Inc. Polymerase chain reaction
supplies were from Qiagen (Chatsworth, CA). Restriction enzymes were
purchased from Promega (Madison, WI).
Isopropyl- -D-galactopyranoside, -mercaptoethanol, aprotinin, and ampicillin were from Sigma. Ultrapure guanidine HCl was
from ICN Pharmaceuticals (Costa Mesa, CA). Oligonucleotides were from
Integrated DNA Technologies (Coralville, IA), and DNA purification kits were from Qiagen.
Expression and Purification of Proteins--
The full-length
human apoE4 and its 22- and 10-kDa fragments were expressed and
purified as described (26) with some modification. The cDNA for
full-length human apoE4, the 22-kDa fragment, or the 10-kDa fragment
were ligated into a thioredoxin fusion expression vector pET32a and
transformed into the E. coli strain BL21 star (DE3). The
transformed E. coli were cultured in LB medium at 37 °C,
and thioredoxin-apoE expression was induced with
isopropyl- -D-galactopyranoside for 3 h. After the
bacterial pellet was sonicated and the lysate was centrifuged to remove
debris, the fusion protein was cleaved with thrombin to remove
thioredoxin from full-length apoE4 or the 22- or 10-kDa fragment. For
the full-length apoE4, the fusion protein was complexed with DMPC
before it was cleaved with thrombin to protect the protease susceptible
internal hinge region (this step was not necessary for the 22- and
10-kDa fragments). After inactivation of the thrombin with
-mercaptoethanol, the mixture was lyophilized and delipidated, and
the apoE pellet was dissolved in 6 M guanidine HCl, pH 7.4, containing 1% -mercaptoethanol. The apoE was isolated by gel
filtration chromatography on a Sephacryl S-300 column. If further
purification (>95%) was needed, the proteins were subjected to gel
filtration with a Superdex 75 column or anion exchange chromatography
with a HiTrap Q column.
Preparation of Large and Small Emulsion Particles--
Emulsion
particles were prepared by sonication and purified by
ultracentrifugation as described (27, 28). Appropriate aliquots of
stock solutions of triolein and egg PC (weight ratios of triolein/PC
were 3.5:1 for large emulsions and 1:1 for small emulsions) were mixed
in a glass tube and dried under a stream of nitrogen, and the tube was
placed into a vacuum desiccator overnight. For large emulsions, the dry
lipids were suspended in Tris buffer (10 mM Tris-HCl, 150 mM NaCl, 0.02% NaN3, 1 mM EDTA, pH
7.4) and sonicated at 80 watts with a Branson sonifier model 350 and
flat tip for 30 min at 50-60 °C under a stream of nitrogen. The
crude emulsions were centrifuged at 3,000 rpm in a Beckman GPR
centrifuge for 15 min to remove titanium. The emulsions were then
centrifuged in a Beckman L7 ultracentrifuge with a SW40Ti rotor at
15,000 rpm for 15 min at 20 °C to remove large particles (creamy
layer) and then washed twice with the buffer by resuspending the
emulsion and spinning at 17,000 rpm for 1 h at 20 °C to remove any contaminating liposomes. The resulting creamy top layer was collected as large emulsion particles. For small emulsions, the dry
lipids were suspended in Tris buffer containing 10% (w/v) sucrose.
After sonication under the conditions described above, the emulsions
were centrifuged as described above to remove titanium and dialyzed
against buffer overnight to remove free sucrose. The emulsions were
then centrifuged at 40,000 rpm at 20 °C for 20 min to separate large
particles (top layer) and small particles (middle layer). The cloudy
middle fraction was collected and respun at 28,000 rpm, 20 °C, for
12 h. The resulting creamy top layer was collected as small
emulsion particles. The weight ratio of triolein to PC in the emulsions
was 6:1-7:1 for large emulsions or 2:1-2.5:1 for small emulsions. The
average particle diameter determined by quasi-elastic light scattering
measurements was 120 ± 10 nm for large emulsions or 35 ± 5 nm for small emulsions, respectively.
Binding of ApoE to Emulsion Particles--
Binding of apoE4 and
its 22- and 10-kDa fragments to emulsion particles was assayed with a
centrifugation method (29, 30). The 14C label was
introduced into the proteins to a specific activity of ~1 µCi/mg
protein by reductive methylation of lysines with [14C]formaldehyde as described (14, 25, 31). This trace
labeling of apoE leads to modification of less than one lysine
residue/apoE molecule, and there is no detectable change in the
physical properties of the protein. Previously, we have established
that reductive methylation of all lysine residues has no effect on the
interaction of apoE with lipid (31). 14C-Labeled apoE4 or
the 22- or 10-kDa fragment (freshly dialyzed from 1%
-mercaptoethanol and 6 M guanidine HCl solution into Tris buffer, pH 7.4) and emulsions (0.3 mg phospholipid/ml) were incubated for 1 h at room temperature with gentle shaking in 1.4 ml of Tris buffer (pH 7.4) containing 0.25 M sucrose. After
incubation, the mixtures were centrifuged in a Beckman L7
ultracentrifuge with a 50Ti rotor at 30,000 rpm (for large emulsions)
or 50,000 rpm (for small emulsions) for 30 min. All of the lipids were
found in the top fraction, and the radioactivity in 200-µl aliquots of the top and bottom fractions was quantitated in a liquid
scintillation counter. The bound apoE concentration was calculated by
subtracting the background free apoE concentration in the top fraction;
the latter was obtained from the results of centrifugation of
lipid-free apoE solutions. Binding data were fitted by nonlinear
regression to a one binding site model with the GraphPad Prizm program.
Isothermal Titration Calorimetry (ITC) Measurements--
Heats
of apoE binding to emulsions were measured with a MicroCal MCS
isothermal titration calorimeter (MicroCal Inc., Northampton, MA) at
25 °C. All solutions were degassed under vacuum before use. The
reactant was placed in the sample cell (1.33 ml) and titrated with
8-10-µl aliquots of the injectant with continual stirring at 400 rpm. Heats of dilution were determined in control experiments by
injecting either protein solution or emulsion suspension into buffer,
and these heats were subtracted from the heats determined in the
corresponding protein-emulsion binding experiments to give the enthalpy
of binding.
Analytical Procedures--
Protein concentrations were
determined by the procedure of Lowry et al. (32). Lipid
concentrations were determined with a phospholipid (Wako Chemicals,
Richmond, VA) and triglyceride (Sigma) assay kits. 14C
radioactivity was assessed by standard liquid scintillation procedures.
Polyacrylamide gel electrophoresis (8-25% gradient) in the presence
of SDS was performed with an Amersham Pharmacia Biotech Phast
electrophoresis system to monitor the purity of the proteins.
 |
RESULTS |
Binding of ApoE to Emulsion Particles--
To assess the lipid
binding properties of full-length apoE4 and its 22- and 10-kDa
fragments, the 14C-labeled proteins were incubated with
small (average diameter of 35 nm) and large (120 nm) emulsion particles
at various protein concentrations at room temperature. Emulsion-bound
protein was separated from unbound protein by ultracentrifugation. All
proteins appeared to bind to the emulsion surface in a saturable manner regardless of particle size (Fig. 1). The
dissociation constant (Kd) and the maximal binding
capacity (Bmax) are listed in Table
I. Full-length apoE4 and the 10-kDa
fragment bound with greater affinity than the 22-kDa fragment to both
small and large emulsions, indicating that the C-terminal domain has a
dominant effect on the lipid binding affinity of full-length apoE4. It should be noted that although a previous study of the distribution of
the 22-kDa fragments of apoE among plasma lipoproteins demonstrated that the 22-kDa fragment does not bind to any triglyceride-rich lipoprotein particles (33), our results clearly showed that the apoE4
22-kDa fragment can bind to some extent to the surface of emulsion
particles.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Binding isotherms of full-length apoE4 and
its 22- and 10-kDa fragments to small (A) and large
(B) emulsion particles. Various concentrations of
full-length apoE4 ( ), the 22-kDa fragment ( ), or the 10-kDa
fragment ( ) were incubated with emulsion particles at a PC to
protein molar ratio in the range of 50-1000 at room temperature. Each
point represents the mean ± S.D. from two independent experiments
each done in duplicate. The amount of bound protein is expressed in
terms of the molar ratio of amino acid/PC in the emulsion surface. The
binding curves were obtained by nonlinear regression fitting to a
one-binding site model.
|
|
The four-helix bundle of the 22-kDa fragment is thought to open on
lipid binding (9-12). However, a recent study using a disulfide bond
engineering approach demonstrated that the initial interaction of the
apoE4 22-kDa fragment with DMPC vesicles does not require the complete
opening of the four-helix bundle (12). To confirm the bundle opening of
the 22-kDa fragment on the emulsion surface, we tested the emulsion
binding of the triple interhelical disulfide-linked apoE4 22-kDa mutant
(12) in which the opening of the four-helix bundle is completely
restricted. This mutant in fact did not bind to either of the emulsion
particles (data not shown), indicating that the 22-kDa fragment binds
to the emulsion surface with the four-helix bundle in an open
conformation, as occurs in the formation of apoE-phospholipid discoidal
particles (10-14).
The binding capacity of full-length apoE4 (around 0.8 amino acid/PC
molecule) was comparable with the previous data of human apoE3 binding
to emulsion particles (34, 35). Assuming that all of the amphipathic
-helices in the apoE molecule interact similarly with lipid, the
Bmax values in terms of amino acids/PC molecule
of all proteins should be identical. However, the
Bmax of full-length apoE4 was much larger than
the Bmax values of the 22- and 10-kDa fragments,
suggesting that the protein-lipid interaction of full-length apoE4 on
the emulsion surface is different from that of each fragment. These
results, together with the finding that the emulsion binding affinity
of the C-terminal fragment is much higher than the N-terminal fragment,
suggest that, at maximal binding, the N-terminal four-helix bundle in
full-length apoE4 does not have an open conformation on the emulsion
surface. This concept has been proposed by Narayanaswami and Ryan (24) for the situation in which other apolipoproteins, such as apoCs, induce
alteration in the conformation of the N-terminal domain of apoE on
spherical lipoprotein particles.
ITC Measurements--
To further compare the interactions of both
domains with lipid, we used ITC to measure the heats of apoE binding to
emulsions. The heat change on apolipoprotein binding to lipid contains
contributions from the protein-lipid interaction and from any resulting
changes in the -helix content of the protein (36, 37). Thus, the heat used or released during the binding process reflects the overall
process of protein-lipid interaction. We determined the enthalpies of
emulsion binding of full-length apoE4 and its 22- and 10-kDa fragments
by injecting small amounts of protein solution into an emulsion
suspension of defined lipid concentration (38).
Fig. 2 shows the results of injecting
10-µl aliquots of full-length apoE4 solution into small and large
emulsions, together with a control injection in which apoE4 was
injected into buffer only. Because of the large lipid-to-protein ratio,
the injected apoE4 is likely to be almost completely bound to the
emulsion surface, and in fact the heats of consecutive injections were virtually identical. Subtracting the heats of dilution yielded the
binding enthalpies. Using the binding constants given in Table I, a
comprehensive set of thermodynamic parameters in apoE4 binding to
emulsions was obtained. Table II
summarizes the enthalpies, free energies, and entropies of binding of
full-length apoE4 and its fragments to small and large emulsions.
Although the binding to both emulsions was found to be an exothermic
process, the binding to large particles was distinctly more exothermic
than binding to small particles for all proteins. As a result, the
binding to large particles is enthalpically driven, whereas that to
small particles is entropically driven. Interestingly, such an effect of emulsion particle size on the thermodynamic properties of apoE-lipid interaction is quite opposite to those found in apolipoprotein A-I
model peptide-vesicle (39) and antibacterial peptide-vesicle (40)
interactions.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Isothermal titration calorimetry for
full-length apoE4 injected into small and large emulsions. Each
peak corresponds to the injection of 10-µl aliquots of a 0.8 mg/ml
solution of full-length apoE4 into pH 7.4 Tris buffer (a),
small emulsions (b), or large emulsions (c). The
PC concentration of both small and large emulsions was 8.0 mM.
|
|
In contrast to the ITC measurement conditions in which there are few
apoE molecules packed on the emulsion surface, the
Bmax values in the 14C-labeled apoE
binding experiments (Table I) reflect the saturated condition of apoE
binding to emulsions. To obtain the thermotropic information for the
apoE-lipid interaction under saturating binding conditions, we
performed the reverse experiment by injecting the emulsions into the
apoE solution. Under this condition, the emulsion surface is always
saturated with apoE molecules. Fig. 3
shows the injections of large emulsion particles into full-length apoE4 or buffer solution. Because the binding enthalpies directly obtained from this ITC measurement were expressed in terms of PC molecules, we
calculated the binding enthalpies per protein using the
Bmax values listed in Table I. For example, we
obtained the binding enthalpy of full-length apoE4 of 39 kcal/mol
protein (Fig. 4B) using the
experimental value of 99 cal/mol PC (Fig. 3) and the Bmax value of 2.6 mmol protein/mol PC (Table I).
Fig. 4 summarizes the binding enthalpies of full-length apoE4 and its
22- and 10-kDa fragments to large emulsion particles under the two
different conditions. If the protein-lipid interaction is independent
of the surface concentration of protein, the binding enthalpies in the
two limiting conditions should be identical. In fact, the binding
enthalpies of the 22- and 10-kDa fragments were similar in the two
conditions, although the binding enthalpies in a saturated condition
(Fig. 4B) tended to be slightly smaller than those in a
diluted condition (Fig. 4A). In contrast, the binding
enthalpy of full-length apoE4 in a saturated condition was much less
exothermic than that in a diluted condition, suggesting that
full-length apoE4 binds to emulsions differently in the two conditions.
In addition, comparison of binding enthalpies among full-length apoE4 and its fragments in a diluted condition demonstrated that the binding
enthalpy of full-length apoE4 is similar to the sum of the enthalpies
of the 22- and 10-kDa fragments, indicating that both the 22- and the
10-kDa domains in full-length apoE4 interact with lipid on the emulsion
surface. It should be noted that the enthalpy of binding of full-length
apoE4 is about 10% less than the sum of the enthalpies for the two
domains (Table II); this small difference may be due to a slight
alteration in the lipid interaction of one domain induced by the other
domain.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Isothermal titration calorimetry for large
emulsions injected into a full-length apoE4 solution. Each peak
corresponds to the injection of 10-µl aliquots of large emulsions (PC
concentration of 8.3 mM) into pH 7.4 Tris buffer
(a) or a 0.26 mg/ml solution of full-length apoE4
(b).
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Binding enthalpies of full-length apoE4 and
its 22- and 10-kDa fragments to large emulsions obtained under two
limiting conditions. A, protein solutions were injected
into excess emulsion at a PC-to-protein molar ratio of >10,000.
B, emulsion was injected into excess protein at a
PC-to-protein molar ratio of <40.
|
|
 |
DISCUSSION |
For high affinity binding to the LDL receptor, apoE must be
associated with lipid. It has been hypothesized that the four-helix bundle of the N-terminal domain undergoes a lipid-induced
reorganization of the helices that exposes the hydrophobic faces to
interact with lipid. Although this reorganization of apoE bound to
phospholipid discs appears to involve opening of the four-helix bundle
structure, it is not clear whether apoE undergoes such a conformational
change on spherical particles. Our findings indicate that apoE bound to
the emulsion particles can adopt two distinct conformations with the
N-terminal four-helix bundle either open or closed; the closed
conformation occurs because of the displacement of the N-terminal
domain from the particle surface by the C-terminal domain that has a
strong lipid affinity.
Effects of Particle Size on ApoE-Lipid Interactions--
It has
been shown that apoE4 has a greater preference for binding to very low
density lipoprotein (VLDL) than high density lipoprotein and that
interaction between N- and C-terminal domains is responsible for this
VLDL preference (41, 42). Although the molecular mechanism of the VLDL
preference of apoE4 is not known, the proposed explanation is that the
domain interaction may stabilize an extended helical structure in the
C-terminal domain that is better accommodated on a less curved VLDL
surface (42). Direct binding experiments to small and large emulsion particles showed no significant differences in the binding parameters for full-length apoE4 and its two domains, except that full-length apoE4 has a slightly higher affinity for small particles than large
particles (Table I). Therefore, apoE4 seems to display no binding
preference within this size range of emulsion particles, which
approximates the VLDL-to-chylomicron size spectrum.
In marked contrast, the thermodynamic binding parameters of apoE were
found to be significantly different between small and large emulsion
particles (Table II). Although the binding free energies of full-length
apoE4 and its fragments are similar for small and large emulsions,
large differences exist in the binding enthalpies and entropies. A
previous ITC study of apolipoprotein A-I model peptide-phospholipid
vesicle interactions demonstrated that the binding of the model
peptides to small vesicles was enthalpically driven with a small
entropy change, whereas that to large vesicles was entropically driven
(39). Thermodynamic binding parameters of apoE to phospholipid vesicles
also appear to have the same particle size
dependence.2 Such an
enthalpy-entropy compensation mechanism can be explained by differences
in the lipid packing in which insertion of -helices into tightly
packed large vesicles leads to a greater increase in the lipid fluidity
than occurs with the more disordered small vesicles (40). However, in
our study, the apoE binding to large particles was found to be
enthalpically driven, whereas that to small particles was entropically
driven. It is not clear why emulsion particle size exerts opposite
effects on thermodynamic binding parameters of apoE. One possible
explanation concerns the different surface structure in emulsions and
phospholipid vesicles. A recent NMR study comparing the surface
structures of large emulsion particles and vesicles indicated that PC
polar headgroups are more separated and exposed to water molecules in
emulsions than in vesicles and that this plays a determinant role in
apolipoprotein binding to the lipid surface (43). In addition,
comparison of surface lipid fluidity using fluorescent probes revealed
that small emulsions have lower surface fluidity than large emulsions
(44). Therefore, the thermodynamic binding parameters in Table II
suggest that the binding of apoE to a relatively well ordered small
emulsion surface causes a greater disordering of surface structure
compared with the situation with the more fluid large emulsion surface.
ApoE Conformation on Emulsion Particles--
Full-length apoE4 and
the 10-kDa fragment bind emulsion particles with much higher affinity
than does the 22-kDa fragment. These observations are consistent with
the previous study demonstrating that these proteins have different
abilities to form discoidal complexes with DMPC: intact apoE3 ~ 10-kDa fragment > 22-kDa fragment (45). These results indicate
that the C-terminal domain dominantly regulates the lipid binding of
full-length apoE as proposed for the lipoprotein association of this
protein (46). Comparison of the binding capacities among full-length
apoE4 and its fragments demonstrated that the binding capacity of
full-length apoE4 is greater than those of the 22- and 10-kDa
fragments. By assuming a surface area of 0.15 nm2/residue
for -helical proteins (47) and 0.7 nm2/molecule for PC
(48) in the emulsion surface monolayer, the fraction of emulsion
surface covered by protein is 17-18% for full-length apoE4 and only
6-7% for the 22- and 10-kDa fragments in both small and large
emulsion particles. This difference in protein surface area on the
emulsion surface between full-length apoE4 and its fragments, together
with the fact that the lipid binding affinity of the C-terminal
fragment is much higher than the N-terminal fragment, suggests that the
N-terminal domain in full-length apoE4 does not interact with lipid
because it is anchored to the emulsion surface by the C-terminal domain.
To test this hypothesis, we measured binding enthalpies of apoE to
large emulsion particles in the two limiting conditions that enable us
to distinguish the two possible conformations on the particle surface
(Fig. 5). The binding enthalpy of
full-length apoE4 was approximately equal to a sum of those of the 22- and 10-kDa fragments at a low surface concentration of protein (Fig. 4A). Together with the fact that the triple interhelical
disulfide-linked apoE4 22-kDa mutant did not bind to emulsion
particles, these results indicate that full-length apoE4 can bind to
the spherical surface with the four-helix bundle in an open
conformation. However, when the protein binding on the emulsion surface
became saturated, the binding enthalpy of full-length apoE4 was less
exothermic and rather similar to that of each fragment alone (Fig.
4B). This suggests that the N-terminal domain in full-length
apoE4 swings into the aqueous phase away from lipid contact probably
because of the binding competition with the C-terminal domain, which
has a strong lipid affinity. This four-helix bundle closed conformation would allow more apoE molecules to bind to the emulsion surface, resulting in the greater binding capacity of full-length apoE4 than
each fragment, as observed in Table I.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Model of two possible conformations of apoE
on spherical particle. This model proposes that at high apoE
surface concentration, the displacement of the N-terminal domain from
the lipid surface by the C-terminal domain causes the N-terminal
four-helix bundle to adopt the closed conformation. At low surface
coverage, the four-helix bundle is open, and all of the -helices are
in contact with the lipid surface. This figure was adapted from
Narayanaswami and Ryan (24).
|
|
Recently, Narayanaswami and Ryan (24) proposed that apoE undergoes a
conformational change upon binding to lipid. The C-terminal domain
anchors the protein to the lipoprotein surface, modulating the receptor
binding properties through alteration of the conformation of the
N-terminal domain between an open lipid-bound receptor-active state and
the globular four-helix bundle, receptor-inactive state. They
hypothesized that other apolipoproteins, such as apoCs, mediate this
conformational change by displacement of the N-terminal domain of apoE
from lipoprotein surface. Our data suggest that such a conformational
change can occur with apoE alone depending upon its surface
concentration, because the C-terminal domain has greatly higher lipid
binding affinity compared with the N-terminal domain. In fact, in a
fibroblast LDL receptor competitive binding assay, the concentrations
of apoE3 required for 50% replacement of 125I-labeled LDL
were 0.01-0.02 and 1.0 µg/ml for apoE-DMPC discs and apoE-bound
VLDL-like emulsion particles, respectively (49). This indicates that
the LDL receptor binding activity of apoE bound to emulsion particles
is much lower than that of apoE-DMPC discs. In addition, Kypreos
et al. (50) demonstrated that overexpression of full-length
apoE induces hyperlipidemia in apoE-deficient mice, whereas the
N-terminal 1-185 residues of apoE are sufficient for the clearance of
apoE-containing lipoprotein remnants by the liver. This suggests that
full-length apoE on lipoprotein particles might be in a conformation
that hinders receptor recognition.
In summary, the current study presents the first complete description
of the thermodynamic binding parameters of full-length apoE4 and the
22- and 10-kDa fragments to lipid particles, allowing us to elucidate
the contributions of each domain of apoE to its interaction with lipid.
Our results suggest that the apoE molecule has two distinct lipid-bound
states involving the N-terminal four-helix bundle open and closed
conformations on the particle surface. This finding may explain in part
why lipoprotein-associated apoE displays variable receptor binding
activity during lipoprotein metabolism.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Siriam Krishnaswamy for
assistance with ITC measurements and Gary Howard and Stephen Ordway for
editorial assistance.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants HL56083 (to S. L. K.) and HL41633 (to K. H. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: National Institute of Health Sciences, 1-1-43 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan.
To whom correspondence should be addressed: Joseph Stokes,
Jr., Research Inst., Children's Hospital of Philadelphia,
Abramson Research Bldg., Suite 302, 3615 Civic Center Blvd.,
Philadelphia, PA 19104-4318. Tel.: 215-590-0587; Fax:
215-590-0583; E-mail: phillipsmi@email.chop.edu.
Published, JBC Papers in Press, August 30, 2001, DOI 10.1074/jbc.M106337200
2
P. Acharya and J. Snow, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
apo, apolipoprotein;
PC, phosphatidylcholine;
LDL, low density lipoprotein;
VLDL, very LDL;
DMPC, 1,2-dimyristoyl phosphatidylcholine;
ITC, isothermal titration
calorimetry.
 |
REFERENCES |
| 1.
|
Mahley, R. W.
(1988)
Science
240,
622-630
|
| 2.
|
Mahley, R. W.,
and Ji, Z. S.
(1999)
J. Lipid Res.
40,
1-16
|
| 3.
|
Mahley, R. W.,
and Rall, S. C., Jr.
(1995)
in
The Metabolic and Molecular Bases of Inherited Disease
(Scriver, C. R.
, Beaudet, A. L.
, Sly, W. S.
, and Valle, D., eds), 7th Ed.
, pp. 1953-1980, McGraw-Hill, New York
|
| 4.
|
Innerarity, T. L.,
Pitas, R. E.,
and Mahley, R. W.
(1979)
J. Biol. Chem.
254,
4186-4190
|
| 5.
|
Weisgraber, K. H.
(1994)
Adv. Protein Chem.
45,
249-302
|
| 6.
|
Weisgraber, K. H.,
and Mahley, R. W.
(1996)
FASEB J.
10,
1485-1494
|
| 7.
|
Wilson, C.,
Wardell, M. R.,
Weisgraber, K. H.,
Mahley, R. W.,
and Agard, D. A.
(1991)
Science
252,
1817-1822
|
| 8.
|
Segelke, B. W.,
Forstner, M.,
Knapp, M.,
Trakhanov, S. D.,
Parkin, S.,
Newhouse, Y. M.,
Bellamy, H. D.,
Weisgraber, K. H.,
and Rupp, B.
(2000)
Protein Sci.
9,
886-897
|
| 9.
|
Weisgraber, K. H.,
Lund-Katz, S.,
and Phillips, M. C.
(1992)
in
High Density Lipoproteins and Atherosclerosis III
(Miller, N. E.
, and Tall, A. R., eds)
, pp. 175-181, Elsevier, Amsterdam
|
| 10.
|
Raussens, V.,
Fisher, C. A.,
Goormaghtigh, E.,
Ryan, R. O.,
and Ruysschaert, J. M.
(1998)
J. Biol. Chem.
273,
25825-25830
|
| 11.
|
Fisher, C. A.,
and Ryan, R. O.
(1999)
J. Lipid Res.
40,
93-99
|
| 12.
|
Lu, B.,
Morrow, J. A.,
and Weisgraber, K. H.
(2000)
J. Biol. Chem.
275,
20775-20781
|
| 13.
|
Fisher, C. A.,
Narayanaswami, V.,
and Ryan, R. O.
(2000)
J. Biol. Chem.
275,
33601-33606
|
| 14.
|
Lund-Katz, S.,
Zaiou, M.,
Wehrli, S.,
Dhanasekaran, P.,
Baldwin, F.,
Weisgraber, K. H.,
and Phillips, M. C.
(2000)
J. Biol. Chem.
275,
34459-34464
|
| 15.
|
Lund-Katz, S.,
Wehrli, S.,
Zaiou, M.,
Newhouse, Y.,
Weisgraber, K. H.,
and Phillips, M. C.
(2001)
J. Lipid Res.
42,
894-901
|
| 16.
|
Gianturco, S. H.,
Gotto, A. M., Jr.,
Hwang, S. L.,
Karlin, J. B.,
Lin, A. H.,
Prasad, S. C.,
and Bradley, W. A.
(1983)
J. Biol. Chem.
258,
4526-4533
|
| 17.
|
Windler, E.,
Chao, Y.,
and Havel, R. J.
(1980)
J. Biol. Chem.
255,
8303-8307
|
| 18.
|
Windler, E.,
and Havel, R. J.
(1985)
J. Lipid Res.
26,
556-565
|
| 19.
|
Borensztajn, J.,
Getz, G. S.,
and Kotlar, T. J.
(1988)
J. Lipid Res.
29,
1087-1096
|
| 20.
|
Sehayek, E.,
Lewin-Velvert, U.,
Chajek-Shaul, T.,
and Eisenberg, S.
(1991)
J. Clin. Invest.
88,
553-560
|
| 21.
|
Brasaemle, D. L.,
Cornely-Moss, K.,
and Bensadoun, A.
(1993)
J. Lipid Res.
34,
455-465
|
| 22.
|
Kowal, R. C.,
Herz, J.,
Weisgraber, K. H.,
Mahley, R. W.,
Brown, M. S.,
and Goldstein, J. L.
(1990)
J. Biol. Chem.
265,
10771-10779
|
| 23.
|
Weisgraber, K. H.,
Mahley, R. W.,
Kowal, R. C.,
Herz, J.,
Goldstein, J. L.,
and Brown, M. S.
(1990)
J. Biol. Chem.
265,
22453-22459
|
| 24.
|
Narayanaswami, V.,
and Ryan, R. O.
(2000)
Biochim. Biophys. Acta
1483,
15-36
|
| 25.
|
Jentoft, N.,
and Dearborn, D. G.
(1983)
Methods Enzymol.
91,
570-579
|
| 26.
|
Morrow, J. A.,
Arnold, K. S.,
and Weisgraber, K. H.
(1999)
Protein Expression Purif.
16,
224-230
|
| 27.
|
Schwiegelshohn, B.,
Presley, J. F.,
Gorecki, M.,
Vogel, T.,
Carpentier, Y. A.,
Maxfield, F. R.,
and Deckelbaum, R. J.
(1995)
J. Biol. Chem.
270,
1761-1769
|
| 28.
|
Saito, H.,
Minamida, T.,
Arimoto, I.,
Handa, T.,
and Miyajima, K.
(1996)
J. Biol. Chem.
271,
15515-15520
|
| 29.
|
Tajima, S.,
Yokoyama, S.,
and Yamamoto, A.
(1983)
J. Biol. Chem.
258,
10073-10082
|
| 30.
|
Saito, H.,
Miyako, Y.,
Handa, T.,
and Miyajima, K.
(1997)
J. Lipid Res.
38,
287-294
|
| 31.
|
Lund-Katz, S.,
Weisgraber, K. H.,
Mahley, R. W.,
and Phillips, M. C.
(1993)
J. Biol. Chem.
268,
23008-23015
|
| 32.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
|
| 33.
|
Weisgraber, K. H.
(1990)
J. Lipid Res.
31,
1503-1511
|
| 34.
|
Yokoyama, S.,
Kawai, Y.,
Tajima, S.,
and Yamamoto, A.
(1985)
J. Biol. Chem.
260,
16375-16382
|
| 35.
|
Derksen, A.,
and Small, D. M.
(1989)
Biochemistry
28,
900-906
|
| 36.
|
Derksen, A.,
Gantz, D.,
and Small, D. M.
(1996)
Biophys. J.
70,
330-338
|
| 37.
|
Gazzara, J. A.,
Phillips, M. C.,
Lund-Katz, S.,
Palgunachari, M. N.,
Segrest, J. P.,
Anantharamaiah, G. M.,
and Snow, J. W.
(1997)
J. Lipid Res.
38,
2134-2146
|
| 38.
|
Seelig, J.
(1997)
Biochim. Biophys. Acta
1331,
103-116
|
| 39.
|
Gazzara, J. A.,
Phillips, M. C.,
Lund-Katz, S.,
Palgunachari, M. N.,
Segrest, J. P.,
Anantharamaiah, G. M.,
Rodrigueza, W. V.,
and Snow, J. W.
(1997)
J. Lipid Res.
38,
2147-2154
|
| 40.
|
Wieprecht, T.,
Apostolov, O.,
and Seelig, J.
(2000)
Biophys. Chem.
85,
187-198
|
| 41.
|
Dong, L. M.,
Wilson, C.,
Wardell, M. R.,
Simmons, T.,
Mahley, R. W.,
Weisgraber, K. H.,
and Agard, D. A.
(1994)
J. Biol. Chem.
269,
22358-22365
|
| 42.
|
Dong, L. M.,
and Weisgraber, K. H.
(1996)
J. Biol. Chem.
271,
19053-19057
|
| 43.
|
Saito, H.,
Tanaka, M.,
Okamura, E.,
Kimura, T.,
Nakahara, M.,
and Handa, T.
(2001)
Langmuir
17,
2528-2532
|
| 44.
|
Massey, J. B.,
and Pownall, H. J.
(1998)
Biophys. J.
74,
869-878
|
| 45.
|
De Pauw, M.,
Vanloo, B.,
Weisgraber, K.,
and Rosseneu, M.
(1995)
Biochemistry
34,
10953-10966
|
| 46.
|
Westerlund, J. A.,
and Weisgraber, K. H.
(1993)
J. Biol. Chem.
268,
15745-15750
|
| 47.
|
Ibdah, J. A.,
and Phillips, M. C.
(1988)
Biochemistry
27,
7155-7162
|
| 48.
|
Nagle, J. F.,
and Tristram-Nagle, S.
(2000)
Curr. Opin. Struc. Biol.
10,
474-480
|
| 49.
|
Dong, L. M.,
Innerarity, T. L.,
Arnold, K. S.,
Newhouse, Y. M.,
and Weisgraber, K. H.
(1998)
J. Lipid Res.
39,
1173-1180
|
| 50.
|
Kypreos, K. E.,
Morani, P.,
van Dijk, K. W.,
Havekes, L. M.,
and Zannis, V. I.
(2001)
Biochemistry
40,
6027-6035
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. T. Alexander, M. Tanaka, M. Kono, H. Saito, D. J. Rader, and M. C. Phillips
Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I
J. Lipid Res.,
July 1, 2009;
50(7):
1409 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Settasatian, P. J. Barter, and K.-A. Rye
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein
J. Lipid Res.,
January 1, 2008;
49(1):
115 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gunzburg, M. A. Perugini, and G. J. Howlett
Structural Basis for the Recognition and Cross-linking of Amyloid Fibrils by Human Apolipoprotein E
J. Biol. Chem.,
December 7, 2007;
282(49):
35831 - 35841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gupta, V. Narayanaswami, M. S. Budamagunta, T. Yamamato, J. C. Voss, and R. O. Ryan
Lipid-induced Extension of Apolipoprotein E Helix 4 Correlates with Low Density Lipoprotein Receptor Binding Ability
J. Biol. Chem.,
December 22, 2006;
281(51):
39294 - 39299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chertova, O. Chertov, L. V. Coren, J. D. Roser, C. M. Trubey, J. W. Bess Jr., R. C. Sowder II, E. Barsov, B. L. Hood, R. J. Fisher, et al.
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.
J. Virol.,
September 1, 2006;
80(18):
9039 - 9052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Chou, W.-P. Jen, Y.-H. Hsieh, M.-S. Shiao, and G.-G. Chang
Structural and Functional Variations in Human Apolipoprotein E3 and E4
J. Biol. Chem.,
May 12, 2006;
281(19):
13333 - 13344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res.,
May 1, 2006;
47(5):
1025 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Hatters, M. S. Budamagunta, J. C. Voss, and K. H. Weisgraber
Modulation of Apolipoprotein E Structure by Domain Interaction: DIFFERENCES IN LIPID-BOUND AND LIPID-FREE FORMS
J. Biol. Chem.,
October 7, 2005;
280(40):
34288 - 34295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Drury and V. Narayanaswami
Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence
J. Biol. Chem.,
April 15, 2005;
280(15):
14605 - 14610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Futamura, P. Dhanasekaran, T. Handa, M. C. Phillips, S. Lund-Katz, and H. Saito
Two-step Mechanism of Binding of Apolipoprotein E to Heparin: IMPLICATIONS FOR THE KINETICS OF APOLIPOPROTEIN E-HEPARAN SULFATE PROTEOGLYCAN COMPLEX FORMATION ON CELL SURFACES
J. Biol. Chem.,
February 18, 2005;
280(7):
5414 - 5422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, D. Atkinson, and D. M. Small
The Interfacial Properties of ApoA-I and an Amphipathic {alpha}-Helix Consensus Peptide of Exchangeable Apolipoproteins at the Triolein/Water Interface
J. Biol. Chem.,
February 11, 2005;
280(6):
4154 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saito, P. Dhanasekaran, D. Nguyen, E. Deridder, P. Holvoet, S. Lund-Katz, and M. C. Phillips
{alpha}-Helix Formation Is Required for High Affinity Binding of Human Apolipoprotein A-I to Lipids
J. Biol. Chem.,
May 14, 2004;
279(20):
20974 - 20981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. MacRaild, C. R. Stewart, Y.-F. Mok, M. J. Gunzburg, M. A. Perugini, L. J. Lawrence, V. Tirtaatmadja, J. J. Cooper-White, and G. J. Howlett
Non-fibrillar Components of Amyloid Deposits Mediate the Self-association and Tangling of Amyloid Fibrils
J. Biol. Chem.,
May 14, 2004;
279(20):
21038 - 21045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Narayanaswami, J. N. Maiorano, P. Dhanasekaran, R. O. Ryan, M. C. Phillips, S. Lund-Katz, and W. S. Davidson
Helix Orientation of the Functional Domains in Apolipoprotein E in Discoidal High Density Lipoprotein Particles
J. Biol. Chem.,
April 2, 2004;
279(14):
14273 - 14279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz
Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E
J. Biol. Chem.,
October 17, 2003;
278(42):
40723 - 40729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saito, P. Dhanasekaran, D. Nguyen, P. Holvoet, S. Lund-Katz, and M. C. Phillips
Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model
J. Biol. Chem.,
June 20, 2003;
278(26):
23227 - 23232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saito, P. Dhanasekaran, D. Nguyen, F. Baldwin, K. H. Weisgraber, S. Wehrli, M. C. Phillips, and S. Lund-Katz
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
J. Biol. Chem.,
April 18, 2003;
278(17):
14782 - 14787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gerritsen, K. E. Kypreos, A. van der Zee, B. Teusink, V. I. Zannis, L. M. Havekes, and K. W. van Dijk
Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain
J. Lipid Res.,
February 1, 2003;
44(2):
408 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Segall, P. Dhanasekaran, F. Baldwin, G. M. Anantharamaiah, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization
J. Lipid Res.,
October 1, 2002;
43(10):
1688 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Gong, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S. C. Fujita, K. Yanagisawa, and M. Michikawa
Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice
J. Biol. Chem.,
August 9, 2002;
277(33):
29919 - 29926.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|